BeiGene, Ltd.
Statements
Income Statement
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.31 | 6.10 | 7.21 | 8.87 | 9.57 | 10.61 | 10.05 | 11.66 | 12.33 | 13.21 | 13.07 | 14.72 | 52.93 | |
| 0.90 | 1.02 | 1.20 | 1.32 | 1.63 | 1.51 | 1.48 | 1.46 | 1.72 | 1.26 | 1.44 | 1.51 | 5.88 | |
| 6.40 | 5.08 | 6.01 | 7.56 | 7.94 | 9.10 | 8.57 | 10.20 | 10.62 | 11.95 | 11.63 | 13.22 | 47.05 | |
| 4.24 | 4.75 | 4.42 | 4.34 | 4.74 | 5.10 | 4.33 | 4.65 | 4.57 | 5.42 | 4.67 | 5.29 | 19.80 | |
| 3.42 | 4.00 | 4.10 | 4.24 | 4.35 | 4.75 | 4.13 | 4.77 | 4.62 | 4.89 | 4.79 | 5.12 | 19.28 | |
| 7.66 | 8.77 | 8.52 | 8.58 | 9.09 | 9.85 | 8.47 | 9.42 | 9.19 | 10.32 | 9.47 | 10.41 | 39.08 | |
| -1.25 | -3.69 | -2.51 | -1.02 | -1.15 | -0.75 | 0.10 | 0.78 | 1.42 | 1.63 | 2.16 | 2.81 | 7.97 | |
| – | – | – | – | – | – | 0.06 | 0.07 | – | 0.51 | 0.28 | 0.34 | – | |
| 2.14 | -3.37 | -2.33 | -1.01 | -0.94 | -0.80 | 0.19 | 0.88 | 1.29 | 1.32 | 2.24 | 2.70 | 7.50 | |
| 0.13 | 0.16 | 0.07 | 0.14 | 0.22 | 0.63 | 0.18 | 0.05 | 0.19 | 0.73 | 0.28 | 0.65 | 1.83 | |
| 2.01 | -3.53 | -2.41 | -1.15 | -1.16 | -1.43 | 0.01 | 0.84 | 1.09 | 0.59 | 1.96 | 2.05 | 5.66 | |
| 2.35 | -3.14 | -2.09 | -0.78 | -0.26 | -0.33 | 0.55 | 1.20 | 1.61 | 2.19 | 2.88 | 3.39 | 10.01 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.